תבנית:תרופה/בקסרו - Bexsero

× ×ª×× × ×ª×¨××¤×

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)	J07AH Meningococcal vaccines
××¨××× ×¤×¢×× (ATC5)	Â Neisseria meningitides group b strain nz98/254 25 MCG âJ07AH06 Neisseria meningitidis group b fhbp fusion protein 50 MCG âJ07AH06 Neisseria meningitidis group b nada protein 50 MCG âJ07AH06 Neisseria meningitidis group b nhba fusion protein 50 MCG âJ07AH06
×¦××¨×ª ××ª×	×ª×× ×©×¨××¨× - I.M
×¦××¨×ª ××× ××	×ª×¨×××£ ××××¨×§×, SUSPENSION FOR INJECTION ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Bexsero is indicated for active immunization of individuals from 2 months of age and older against invasive meningococcal disease caused by Neisseria meningitidis group B.
×ª×× ××ª:× ×ª×× × ×¡×/×ª×¨××¤×/××§×¡×¨× - Bexsero
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	Â ×¢××× ××¨××¤× 21.09.2022 ××××¨× ××¢××× ××¨××¤× 28.05.2019 ××××¨× ××¢××× ××¨××¤× 09.12.2018 Â ××××¨× ××¢××× 24.11.2021 ××××¨× ××¢××× 04.08.2021 ××××¨× ××¢××× 19.10.2020 ××××¨× ××¢××× 29.02.2020

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 24.11.2021 ×¢××× ××¦×¨×× ×× ××××ª Patient information leaflet â24.11.2021 ×¢××× ××¦×¨×× ×¢×¨×××ª ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 24.11.2021

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××§×¡×¨× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	-
××××¢ ××¨×©×ª	-
×©× ××¦×¨×	GLAXO SMITHKLINE VACCINES S.R.L., ITALY
×©× ××¢× ××¨××©××	GLAXO SMITH KLINE (ISRAEL) LTD
×¨××©×××	×ª××¨×× ×××©×: 01/2015. ×¨××©××× ××ª××¨××: 03/2016
×ª××¨×× ×¢×××× ×××¨××	14/05/19

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

××£ ×× × ××¦×¨ ×¢× ××× ××× ××××××¨ ×ª×× ××ª ×¢× ×¤×¨×× ××ª×¨××¤×.

{{×ª×¨××¤×/××§×¡×¨× - Bexsero}}

×:

{{×ª×¨××¤×/××§×¡×¨× - Bexsero
| ×©× ××¤×¨×××¨=×¢×¨× ×××© (×××¨×¡ ××ª ××¢×¨× ×©×××× ×××××¨)
}}

השינוי האחרון נעשה בֹ־2 בספטמבר 2023 ב־15:51

ויקיתרופות